CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iotsova, V.
Right arrow Articles by Stehelin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iotsova, V.
Right arrow Articles by Stehelin, D.

Cell Growth & Differentiation, Vol 7, Issue 5 629-634, Copyright © 1996 by American Association of Cancer Research


ARTICLES

Down-regulation of fibronectin gene expression by the p53 tumor suppressor protein

V Iotsova and D Stehelin
Molecular Oncology Unit, Centre National de la Recherche Scientifique, URA 1160, Institut Pasteur de Lille, France.

The tumor suppressor p53 protein down-regulates in vitro the expression of several cellular and viral promoters. However, it is not clear whether this down-regulation reflects equivalent modulation of the activity of these promoters in vivo. Here, we propose a suitable system to assess the effect of p53 on gene expression in vivo: the pair of p53 antisense-transfected and parental HeLa cells. The low amount of free wild-type p53 in HeLa cells seems still sufficient for the repression of several promoters that might be derepressed in p53 antisense-transfected HeLa cells. We have used this system for the demonstration both in vivo and in vitro of the repression of the fibronectin (FN) gene promoter by wild-type p53. The protein and mRNA amounts for FN were increased in the p53 antisense-transfected HeLa clones. This was accompanied by the restoration of the FN network in these cells. FN promoter constructs fused to the chloramphenicol acetyltransferase reporter gene were specifically repressed by wild-type p53 in different cell lines. Integrin alpha 5 beta 1 clustering was changed in the sites of focal contacts, most probably representing its relocalization as a consequence of the increased amounts of fibronectin.


This article has been cited by other articles:


Home page
Cancer DiscoveryHome page
E. Powell, D. Piwnica-Worms, and H. Piwnica-Worms
Contribution of p53 to Metastasis
Cancer Discovery, April 1, 2014; 4(4): 405 - 414.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. K. Ghosh, S. Bhattacharyya, and J. Varga
The Tumor Suppressor p53 Abrogates Smad-dependent Collagen Gene Induction in Mesenchymal Cells
J. Biol. Chem., November 12, 2004; 279(46): 47455 - 47463.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. A. Sablina, P. M. Chumakov, and B. P. Kopnin
Tumor Suppressor p53 and Its Homologue p73{alpha} Affect Cell Migration
J. Biol. Chem., July 18, 2003; 278(30): 27362 - 27371.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
R. A. Johnson, T. A. Ince, and K. W. Scotto
Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element
J. Biol. Chem., July 20, 2001; 276(29): 27716 - 27720.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
R. A. Johnson, T. A. Ince, and K. W. Scotto
Transcriptional Repression by p53 through Direct Binding to a Novel DNA Element
J. Biol. Chem., July 20, 2001; 276(29): 27716 - 27720.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1996 by the American Association of Cancer Research.